Magazine

"Make-or-Break Time for Cancer Drugs" (Personal Business, June 8, 2009)

Posted on June 17, 2009

"Make-or-Break Time for Cancer Drugs" (Personal Business, June 8, 2009) mistakenly said that biotech company Celgene has a forthcoming treatment for hepatitis C. Celgene is not focusing on this disease.

Business Exchange: What your peers are reading.

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus